» Articles » PMID: 35696243

Characterization of a Fluorescent Glucose Derivative 1-NBDG and Its Application in the Identification of Natural SGLT1/2 Inhibitors

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Glucose is an important energy source for cells. Glucose transport is mediated by two types of glucose transporters: the active sodium-coupled glucose cotransporters (SGLTs), and the passive glucose transporters (GLUTs). Development of an easy way to detect glucose uptake by the cell can be valuable for research. 1-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-1-deoxy-d-glucose (1-NBDG) is a newly synthesized fluorescent glucose analogue. Unlike 2-NBDG, which is a good substrate of GLUTs but not SGLTs, 1-NBDG can be transported by both GLUTs and SGLTs. Thus, 1-NBDG is useful for the screening of SGLT1 and SGLT2 inhibitors. Here we further characterized 1-NBDG and compared it with 2-NBDG. The fluorescence of both 1-NBDG and 2-NBDG was quenched under alkaline conditions, but only 1-NBDG fluorescence could be restored upon neutralization. HPLC analysis revealed that 2-NBDG was decomposed leading to loss of fluorescence, whereas 1-NBDG remained intact in a NaOH solution. Thus, after cellular uptake, 1-NBDG fluorescence can be detected on a plate reader simply by cell lysis in a NaOH solution followed by neutralization with an HCl solution. The fluorescence stability of 1-NBDG was stable for up to 5 h once cells were lysed; however, similar to 2-NBDG, intracellular 1-NBDG was not stable and the fluorescence diminished substantially within one hour. 1-NBDG uptake could also be detected at the single cell level and inhibition of 1-NBDG uptake by SGLT inhibitors could be detected by flow cytometry. Furthermore, 1-NBDG was successfully used in a high-throughput cell-based method to screen for potential SGLT1 and SGLT2 inhibitors. The SGLT inhibitory activities of 67 flavonoids and flavonoid glycosides purified from plants were evaluated and several selective SGLT1, selective SGLT2, as well as dual SGLT1/2 inhibitors were identified. Structure-activity relationship analysis revealed that glycosyl residues were crucial since the aglycon showed no SGLT inhibitory activities. In addition, the sugar inter-linkage and their substitution positions to the aglycon affected not only the inhibitory activities but also the selectivity toward SGLT1 and SGLT2.

Citing Articles

A Comprehensive Review of Molecular Mechanisms, Pharmacokinetics, Toxicology and Plant Sources of Juglanin: Current Landscape and Future Perspectives.

Rutkowska M, Witek M, Olszewska M Int J Mol Sci. 2024; 25(19).

PMID: 39408653 PMC: 11476773. DOI: 10.3390/ijms251910323.


Early use of SGLT2 inhibitors reduces the progression of diabetic kidney disease: a retrospective cohort study.

Pang S, Li X Am J Transl Res. 2024; 16(9):4967-4978.

PMID: 39398587 PMC: 11470299. DOI: 10.62347/ARYA8831.


Discovery of New Glucose Uptake Inhibitors as Potential Anticancer Agents by Non-Radioactive Cell-Based Assays.

Hung H, Li L, Guh J, Kung F, Hsu L Molecules. 2022; 27(22).

PMID: 36432207 PMC: 9692963. DOI: 10.3390/molecules27228106.

References
1.
Barron C, Bilan P, Tsakiridis T, Tsiani E . Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment. Metabolism. 2016; 65(2):124-39. DOI: 10.1016/j.metabol.2015.10.007. View

2.
Yoshioka K, Saito M, Oh K, Nemoto Y, Matsuoka H, Natsume M . Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells. Biosci Biotechnol Biochem. 1996; 60(11):1899-901. DOI: 10.1271/bbb.60.1899. View

3.
Choi C . Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors from Natural Products: Discovery of Next-Generation Antihyperglycemic Agents. Molecules. 2016; 21(9). PMC: 6273509. DOI: 10.3390/molecules21091136. View

4.
Zou C, Wang Y, Shen Z . 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods. 2005; 64(3):207-15. DOI: 10.1016/j.jbbm.2005.08.001. View

5.
Chen J, Mangelinckx S, Adams A, Wang Z, Li W, De Kimpe N . Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Nat Prod Commun. 2015; 10(1):187-200. View